Table 1: Baseline variables.
Variable |
IVM |
IVM + HCQ + AZM |
Overall |
P value (test) |
Total Numbers |
30 |
31 |
61 |
|
Mean Age (SD) years. |
41.6 (2.6) |
39.2 (2.9) |
40.4 (1.9) |
0.558 (ttest) |
Sex (Male %) |
20 (66) |
19 (61) |
39 (63) |
0.662 (chi2) |
Dose of Ivermectin (number of 3 mg tablets) |
5.07 (0.12) |
5.07 (0.13) |
5.07 (0.69) |
0.98 (ttest) |
Oxygen use |
1 |
2 |
3 |
0.573 (chi2) |
Ventilator |
2 |
0 |
2 |
0.144 (PearsonChi) |
Vaccination |
0 |
0 |
0 |
|
Hematology |
||||
Hemoglobin g/dl |
12.9 (2.4) |
12.6 (2.4) |
12.7 (2.4) |
0.577 |
WBC × 109 cells/liter |
9.76 (2.84) |
9.33 (2.13) |
9.53 (2.49) |
0.501 |
Lymphocyte × 109 cells/liter |
32.4 (13.0) |
37.4 (13.6) |
34.9 (13.5) |
0.150 |
Neutrophils × 109 cells/liter |
58.6 (15.3) |
59.8 (12.5) |
59.2 (13.9) |
0.723 |
Neutrophil to Lymphocyte ratio(NLR) |
2.49 |
2.05 |
2.27 |
0.443 |
Platelet count × 109 cells/liter |
211.5 (62.3) |
196.9 (55.5) |
204.1 (58.9) |
0.341 |
Viral Load Cycle Threshold Ct. |
||||
N-gene CT |
27.4 (1.03) |
25.7 (1.14) |
26.5 (6.02) |
0.27 (ttest) |
E-gene CT |
21.2 (0.75) |
20.7 (20.9) |
21 |
0.654 |
Inflammatory markers |
||||
ESR ml/h Westergren |
12.8 (0.51) |
12.7 (0.43) |
12.78 (0.33) |
0.816 (ttest) |
C-reactive Protein mg/l |
14.7 (1.01) |
14.7 (1.01) |
14.67 (0.71) |
0.995 (ttest) |
D-dimer ng/ml FEU (Fibrinogen equivalent Unit) |
223.9 (18.8) |
220.5 (21.6) |
222.2 (28.2) |
0.525 (ttest) |
SpO2% |
93.8 (3.5) |
92.0 (4.7) |
92.9 (4.2) |
0.09 (ttest) |
Symptoms at baseline (%) |
||||
Diarrhea |
6 (20) |
8 (27.6) |
14 (23.7) |
0.493 (chi2) |
Anosmia |
6 (20) |
6 (20) |
12 (20) |
1.000 (chi2) |
Ageusia |
5 (16.7) |
6 (19.3) |
11 (18.0) |
0.785 (Fisher’s exact) |
Dyspnea |
8 (26.7) |
7 (23.3) |
15 (25) |
0.766 (Fisher’s exact) |
Headache |
14 (46.7) |
16 (53.3) |
30 (50) |
0.606 (Fisher’s exact) |
Cough |
20 (66.7) |
24 (77.4) |
44 (72.1) |
0.349 |
IVM: Ivermectin; HCQ: Hydroxychloroquine; AZM: Azithromycin.